Aptevo Therapeutics, Inc. (APVO)

8.57 -0.44 (-4.83%) USD  |  NASDAQ  |  Jan 15, 10:32
More

Aptevo Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for APVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Dermata Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade